Medical cannabis company Maricann Group Inc.’s chair and a board director have stepped down and its recent $70 million financing is in limbo as Canada’s biggest securities regulator conducts a review of certain trades by its directors. The company, based in Toronto and Munich, also announced that its chairman Neil Tabatznik and Raymond Stone, a director, have resigned from the company’s board. “Prior to this, the company was unaware of the matter,” Maricann said in a statement Wednesday. A day later, Tabatznik sold 438,000 shares at roughly $4.26 each, or a total $1.864 million. And on Jan. 25, he sold another 5,000 shares for $4.25 each, or $21,250.

Source: thestar February 28, 2018 16:41 UTC